<?xml version="1.0" encoding="UTF-8"?>
<fig id="viruses-11-01064-f004" orientation="portrait" position="float">
 <label>Figure 4</label>
 <caption>
  <p>Protective activity of Ery-Est against ZIKV infection in lethal mouse models. Three groups of A129 mice were infected with 1 × 10
   <sup>5</sup> plaque forming units (PFU) ZIKV, followed by treatment of Ery-Est, Ery, and vehicle at 50 mg/kg respectively (
   <italic>n</italic> = 8). Mice administrated with heat-inactivated ZIKV (iZIKV) or only administrated with Ery-Est and Ery were used as mock controls. (
   <bold>A</bold>) Viral RNA load in sera of A129 mice 2 dpi, mice were retro-orbitally bled to measure the RNA load by RT-qPCR. (
   <bold>B</bold>) Survival status, (
   <bold>C</bold>) body weight, and (
   <bold>D</bold>) clinical score were recorded every day until 21 dpi. Data are presented as means ± SD for (
   <bold>A</bold>) and (
   <bold>C</bold>). Statistical analysis: Mann–Whitney test for (
   <bold>A</bold>); Log-rank (Mantel Cox) for (
   <bold>B</bold>). ns = not significant. ** 
   <italic>p</italic> &lt; 0.01.
  </p>
 </caption>
 <graphic xlink:href="viruses-11-01064-g004" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
